It names kidney function through eGFR and creatinine, plus sodium and potassium levels, as the measures that shape how much fluid is appropriate
Retatrutide is developed by Eli Lilly with expected approval in late 2026 or early 2027
GLP-1 agonists, for instance, have the ability to improve multiple metabolic and neurologic functions, while metformin increases oxidative stress
Overview of GLP-1 Analogue Drugs: Brands, Companies & Clinical Uses GLP-1 analogues have transformed the treatment landscape for Type 2 Diabetes and obesity management offering better glycemic control, cardiovascular benefits, and effective weight loss
Which is better: Saxenda or semaglutide
Budget Constraints The Problem: Simply cant afford $1,000+/month long-term Need medication for 12-18+ months for full results $12,828+/year exceeds weight loss budget Other financial priorities compete The Solution: Affordable alternatives make long-term treatment financially sustainable